Peptide therapeutics contract active pharmaceutical ingredient manufacturing market to reach $4.11 billion by 2030 at 7.3% cagr, driven by rising prevalence of diabetes.
Read More
Peptide therapeutics market to reach $83.57 billion by 2030 at 11.2% cagr, driven by increase in prevalence of chronic diseases.
Read More
Peptide supplements market to reach $5.89 billion by 2030 at 10.2% cagr, driven by rising awareness of health and wellness.
Read More
Peptide drug conjugates market to reach $7.44 billion by 2030 at 15.3% cagr, driven by growing demand for personalized treatments.
Read More
Peptide based metabolic disorders therapeutics market to reach $63.7 billion by 2030 at 13.0% cagr, driven by rising prevalence of obesity.
Read More
Peptide antibiotics market to reach $9.04 billion by 2030 at 9.3% cagr, driven by increase in prevalence of infectious diseases.
Read More
Peptide and oligonucleotide cdmo market to reach $4.03 billion by 2030 at 10.5% cagr, driven by growing adoption of personalized medicine.
Read More
Peptide and anticoagulant drugs market to reach $2.47 billion by 2030 at 9.9% cagr, driven by rising prevalence of chronic diseases.
Read More
The global pentavalent market to reach $3.39 billion by 2030 at 4.7% cagr, driven by rising prevalence of diphtheria.
Read More
Pegfilgrastim biosimilars market to reach $2.65 billion by 2030 at 6.7% cagr, driven by increased incidence of cancer.
Read More